Concord
HR 8857 · 119th Congress

To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.

This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Why?

Every bill carries a core record (title, sponsor, latest action) that Concord fetches up front. The detailed sections — cosponsors, action history, subjects, titles, and summaries — live behind separate Congress.gov endpoints, so they're fetched on demand rather than for all 50,000+ bills at once. Until a bill has been enriched, those sections stay empty.

Brief

Executive summary AI-generated

No executive summary yet — generate one to distill the facts below into a few sentences.

Sponsor
Joseph Morelle
Policy area
—
Introduced
2026-05-15
Chamber
House
Status
2026-05-15 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Coalition
0 cosponsors (0 original)
0 actions on file 0 recorded votes
No CRS summary available for this bill.
Generating…

Latest action

2026-05-15 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries

Summaries not yet fetched.

Sponsor

Joseph Morelle

Cosponsors

Cosponsors not yet fetched.

Vote history

No votes recorded for this bill yet.

Action history

Action history not yet fetched.

Subjects

Subjects not yet fetched.

Titles

Titles not yet fetched.